Inventor · Bottmingen, CH

Thomas Ullrich

12Patents
2h-index
53Co-inventors
53Inventor score

Filing activity: Jul 28, 2008 → Jul 28, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US10710980B2 Aminopyridine derivatives and their use as selective ALK-2 inhibitors Emerging Cross-Sectional Technologies 4 Active
US10947218B2 Aminopyridine derivatives and their use as selective ALK-2 inhibitors Emerging Cross-Sectional Technologies 2 Active
US9623012B2 Formulation comprising benzothiazolone compound Human Necessities 1 Active
US8933108B2 Benzothiazolone compound Emerging Cross-Sectional Technologies 1 Active
US10112907B2 Substituted indazoles for treating tendon and/or ligament injuries Chemistry; Metallurgy 1 Active
US10766894B2 Aza-indazole compounds for use in tendon and/or ligament injuries Human Necessities 1 Active
US10251868B2 Benzothiazolone compound Emerging Cross-Sectional Technologies 0 Active
US8263585B2 Organic compounds Chemistry; Metallurgy 0 Active
US11203595B2 Aza-indazole compounds for use in tendon and/or ligament injuries Human Necessities 0 Active
US9913828B2 Benzothiazolone compound Emerging Cross-Sectional Technologies 0 Active
US9051326B2 Pyrazoline derivatives and their use as selective androgen receptor modulators Human Necessities 0 Active
US11160797B2 Pyridinone derivatives and their use as selective ALK-2 inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.